"Paid to Endure": Paid Research Participation, Passivity, and the Goods of Work.

A growing literature documents the existence of individuals who make a living by participating in phase I clinical trials for money. Several scholars have noted that the concerns about risks, consent, and exploitation raised by this phenomenon apply to many (other) jobs, too, and therefore proposed...

Descripción completa

Detalles Bibliográficos
Publicado en:American Journal of Bioethics Vol. 19; no. 9; pp. 11 - 21
Autor principal: Malmqvist, Erik
Formato: review Journal Article
Publicado: Taylor & Francis Ltd Sep2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=138105547&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 138105547
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15265161
        FKZ
      jtl: American Journal of Bioethics
      issn: 15265161
      maglogo: N
    pubinfo:
      dt: Sep2019
      vid: 19
      iid: 9
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        138105547
        138105547
        138105547
        10.1080/15265161.2019.1630498
        138105547
      ppf: 11
      ppct: 10
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: "Paid to Endure": Paid Research Participation, Passivity, and the Goods of Work.
      aug:
        au: Malmqvist, Erik
        affil: University of Gothenburg
      sug:
        subj:
          Clinical Trials
          Research Subject Recruitment Economics
          Research Subjects Psychosocial Factors
          Income
          Adverse Health Care Event Risk Factors
          Consent (Research)
          Motivation
          Research Ethics
          Pharmaceutical Companies
          Government Regulations
          Philosophy
      ab: A growing literature documents the existence of individuals who make a living by participating in phase I clinical trials for money. Several scholars have noted that the concerns about risks, consent, and exploitation raised by this phenomenon apply to many (other) jobs, too, and therefore proposed improving subject protections by regulating phase I trial participation as work. This article contributes to the debate over this proposal by exploring a largely neglected worry. Unlike most (other) workers, subjects are not paid to produce or achieve anything but to have things done to them. I argue that this passivity is problematic for reasons of distributive justice. Specifically, it fails to enable subjects to realize what Gheaus and Herzog call "the goods of work"—a failure not offset by adequate opportunities to realize these goods outside of the research context. I also consider whether granting subjects worker-type protections would accommodate this concern.
      pubtype: Academic Journal
      doctype:
        review
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N